Gates Foundation commits to providing lenacapavir as PrEP next year

Back to the "HIV and Co-Infections News" list

On 2 June 2025, the Gates Foundation celebrated its 25th anniversary with a broadcast talk and panel discussion about healthcare in Africa and future international support.

Although not covered in detail, it is important that future plans include a commitment to roll out access to 6-monthly injectable lenacapavir as PrEP “over the next year”.

Read the full coverage of the event at HIV i-Base.

 

Source : HIV i-Base

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.